The Cooper Companies, Inc.
- COO
- NASDAQ
- Medical - Instruments & Supplies
- Contact Lenses (CooperVision)
- Surgical Products (CooperSurgical)
$58.16
Today +0.38%Quote Oct 19, 2026, 08:00 PM UTC
+5.19%over the last month
Max drawdown −5.4%From 1-month high 0.0%3 months −18.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Cooper Companies
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses.
Where the money comes from
Q3 2026 revenue $1.07B
- Coopervision Segment$717.0M67.2%
- Coopersurgical Segment$349.2M32.8%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Employees
15,000
Market value
$11.06B
Quote Oct 19
Floor
$57.69
0.8% below price
Resistance
$59.49
2.3% above price
Price vs analyst targets
28 analysts
Lowest target
$59.00Highest target
$75.00
$59.00Highest target
$75.00
- Price $58.16
- Average target $65.11
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 12% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about COOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free